Products and Pipeline  
Our current focus is on: 

Intravesical BCG* therapy for superficial Urinary Bladder Cancer

Infant and adult BCG* vaccine against tuberculosis, leprosy, tuberculoid meningitis, and potentially COVID-19

Insulin for diabetes management and control

*BCG based on the Pasteur strain
 
Our ongoing research pipeline includes:

Other vaccines: meningococcal vaccines, MMR vaccine against measles, mumps and rubella and Human Papilloma Virus (HPV)

Anti-inflammatory therapies with applications on a variety of areas including asthma 

BCG based therapies under study for colon cancer and Inflammatory Bowel Disease 

Recombinant BCG (patented) for invasive and metastatic bladder cancer

In addition, we are continuing to expand commercial operations including our current distribution of generic medications to several countries.